A three-dimensional model of the Cdc2 protein kinase: localization of cyclin- and Suc1-binding regions and phosphorylation sites

The Cdc2 protein kinase requires cyclin binding for activity and also binds to a small protein, Suc1. Charged-to-alanine scanning mutagenesis of Cdc2 was used previously to localize cyclin A- and B- and Suc1-binding sites (B. Ducommun, P. Brambilla, and G. Draetta, Mol. Cell. Biol. 11:6177-6184, 1991). Those sites were mapped by building a Cdc2 model based on the crystallographic coordinates of the catalytic subunit of cyclic AMP-dependent protein kinase (cAPK) (D. R. Knighton, J. Zheng, L. F. Ten Eyck, V. A. Ashford, N.-H. Xuong, S. S. Taylor, and J. M. Sowadski, Science 253:407-414, 1991). On the basis of this model, additional mutations were made and tested for cyclin A and Suc1 binding and for kinase activity. Mutations that interfere with cyclin A binding are localized primarily on the small lobe near its interface with the cleft and include an acidic patch on the B helix and R-50 in the highly conserved PSTAIRE sequence. Two residues in the large lobe, R-151 and T-161, influence cyclin binding, and both are at the surface of the cleft near its interface with the PSTAIRE motif. Cyclin-dependent phosphorylation of T-161 in Cdc2 is essential for activation, and the model provides insights into the importance of this site. T-161 is equivalent to T-197, a stable phosphorylation site in cAPK. On the basis of the model, cyclin binding very likely alters the surface surrounding T-161 to allow for T-161 phosphorylation. The two major ligands to T-197 in cAPK are conserved as R-127 and R-151 in Cdc2. The equivalent of the third ligand, H-87, is T-47 in the PSTAIRE sequence motif. Once phosphorylated, T-161 is predicted to play a major structural role in Cdc2, comparable to that of T-197 in cAPK, by assembling the active conformation required for peptide recognition. The inhibitory phosphorylation at Y-15 also comes close to the cleft interface and on the basis of this model would disrupt the cleft interface and the adjacent peptide recognition site rather than prevent ATP binding. In contrast to cyclin A, both lobes influence Suc1 binding; however, the Suc1-binding sites are far from the active site. Several mutants map to the surface in cAPK, which is masked in part by the N-terminal 40 residues that lie outside the conserved catalytic core. The other Suc1-binding site maps to the large lobe near a 25-residue insert and includes R-215.

[1]  D. Knighton,et al.  2.0 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent. , 1993, Acta crystallographica. Section D, Biological crystallography.

[2]  H. Shuntoh,et al.  Autoactivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197 , 1993, Molecular and cellular biology.

[3]  H. Piwnica-Worms,et al.  Mechanisms of p34cdc2 regulation , 1993, Molecular and cellular biology.

[4]  E. Karsenti,et al.  Phosphorylation and activation of human cdc25‐C by cdc2‐‐cyclin B and its involvement in the self‐amplification of MPF at mitosis. , 1993, The EMBO journal.

[5]  P. Russell,et al.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. , 1993, The EMBO journal.

[6]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. , 1993, Biochemistry.

[7]  D. Knighton,et al.  Structural basis of the intrasteric regulation of myosin light chain kinases. , 1992, Science.

[8]  A. N. Meyer,et al.  Requirement of mosXe protein kinase for meiotic maturation of Xenopus oocytes induced by a cdc2 mutant lacking regulatory phosphorylation sites , 1992, Molecular and cellular biology.

[9]  G. McKnight,et al.  Mutations in the catalytic subunit of cAMP-dependent protein kinase result in unregulated biological activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Morgan,et al.  Activation of human cyclin-dependent kinases in vitro. , 1992, Molecular biology of the cell.

[11]  G. Draetta,et al.  The consensus sequences for cdc2 kinase and for casein kinase‐2 are mutually incompatible A study with peptides derived from the β‐subunit of casein kinase‐2 , 1992, FEBS letters.

[12]  D. Knighton,et al.  Systematic mutational analysis of cAMP-dependent protein kinase identifies unregulated catalytic subunits and defines regions important for the recognition of the regulatory subunit. , 1992, The Journal of biological chemistry.

[13]  R. Pepperkok,et al.  Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[14]  D. Lew,et al.  A proliferation of cyclins. , 1992, Trends in cell biology.

[15]  P. Russell,et al.  The cdc25 M-phase inducer: An unconventional protein phosphatase , 1992, Cell.

[16]  H. Tung,et al.  Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2. , 1992, European journal of biochemistry.

[17]  H.Y. Lim Tung,et al.  Interaction between the cell cycle control proteins p34cdc2 and p9CKShs2: Evidence for two cooperative binding domains in p9CKShs2 , 1992 .

[18]  M. Kirschner,et al.  Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. , 1992, Molecular biology of the cell.

[19]  L. Johnson,et al.  Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. , 1992, Journal of molecular biology.

[20]  D. Beach,et al.  Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins , 1991, Cell.

[21]  G. Draetta,et al.  Mutations at sites involved in Suc1 binding inactivate Cdc2 , 1991, Molecular and cellular biology.

[22]  B. Franza,et al.  cdc2 phosphorylation is required for its interaction with cyclin. , 1991, The EMBO journal.

[23]  E. Nigg,et al.  Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. , 1991, The EMBO journal.

[24]  P. Nurse,et al.  Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. , 1991, The EMBO journal.

[25]  T. Hunter,et al.  Cyclin-dependent kinases: a new cell cycle motif? , 1991, Trends in cell biology.

[26]  Marc W. Kirschner,et al.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2 , 1991, Cell.

[27]  T. Hunt,et al.  Cyclins and their partners: from a simple idea to complicated reality. , 1991, Seminars in cell biology.

[28]  Karen Lundgren,et al.  mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2 , 1991, Cell.

[29]  E. Nigg,et al.  Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. , 1991, The EMBO journal.

[30]  R. Steinberg,et al.  A kinase-negative mutant of S49 mouse lymphoma cells is defective in posttranslational maturation of catalytic subunit of cyclic AMP-dependent protein kinase , 1991, Molecular and cellular biology.

[31]  S. Forsburg,et al.  Cell cycle regulation in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe. , 1991, Annual review of cell biology.

[32]  G. Draetta,et al.  Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. , 1990, Trends in biochemical sciences.

[33]  Tony Hunter,et al.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B , 1990, Nature.

[34]  P. Russell,et al.  Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. , 1990, Genes & development.

[35]  L. Levin,et al.  Association of catalytic and regulatory subunits of cyclic AMP-dependent protein kinase requires a negatively charged side group at a conserved threonine , 1990, Molecular and cellular biology.

[36]  P. Nurse,et al.  Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication , 1990, Cell.

[37]  Kathleen L. Gould,et al.  Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis , 1989, Nature.

[38]  B. Franza,et al.  A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells , 1989, Cell.

[39]  D. Beach,et al.  The fission yeast cdc2/cdc13/suc1 protein kinase: Regulation of catalytic activity and nuclear localization , 1989, Cell.

[40]  Sergio Moreno,et al.  Regulation of p34cdc2 protein kinase during mitosis , 1989, Cell.

[41]  J. Newport,et al.  Fission yeast p13 blocks mitotic activation and tyrosine dephosphorylation of the Xenopus cdc2 protein kinase , 1989, Cell.

[42]  J. Wells,et al.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. , 1989, Science.

[43]  S. Reed,et al.  The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex , 1989, Molecular and cellular biology.

[44]  D. Beach,et al.  Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement , 1988, Cell.

[45]  D. Beach,et al.  p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. , 1987, The EMBO journal.

[46]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[47]  J. Hayles,et al.  suc1 is an essential gene involved in both the cell cycle and growth in fission yeast , 1986, The EMBO journal.

[48]  A. Lesk,et al.  The relation between the divergence of sequence and structure in proteins. , 1986, The EMBO journal.

[49]  S. Taylor,et al.  Affinity labeling of cAMP-dependent protein kinase with p-fluorosulfonylbenzoyl adenosine. Covalent modification of lysine 71. , 1981, The Journal of biological chemistry.

[50]  H. Penefsky Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. , 1977, The Journal of biological chemistry.

[51]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.